Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Researchers say longer clinical trials will be needed before making any final conclusions about GLP-1 drugs and cancer
What will it be
The patient provided written informed consent for the publication of research details and clinical images
(2025) 9:bvaf022
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg for 4 weeks, then increased in 2.5 mg increments to a target dose of 5-15 mg based on glycemic control and tolerability
Bikou, A., Dermiki-Gkana, F., Penteris, M., Constantinides, T
US$ 28.94
US$ 27.96
US$ 28.53
US$ 27.46
US$ 23.95
US$ 23.15
US$ 23.42
US$ 24.54
